Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Earum Pharmaceuticals IPO is a fixed price issue of ₹6.65 crores. The issue is entirely a fresh issue of 0.18 crore shares of ₹6.65 crore.
Earum Pharmaceuticals IPO bidding started from Jun 21, 2019 and ended on Jun 26, 2019. The allotment for Earum Pharmaceuticals IPO was finalized on Jul 1, 2019. The shares got listed on BSE SME on Jul 4, 2019.
Earum Pharmaceuticals IPO price is ₹36.00 per share . The lot size for an application is 3,000. The minimum amount of investment required by an individual investor (retail) is ₹1,08,000 (3000 shares). The minimum lot size investment for HNI is 2 lots (6,000 shares), amounting to ₹2,16,000.
Hem Securities Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The market maker of the company is Hem Securities Ltd..
Refer to Earum Pharmaceuticals IPO RHP for detailed Information.
| IPO Date | June 21, 2019 to June 26, 2019 |
| Listing Date | July 4, 2019 |
| Face Value | ₹10 per share |
| Issue Price Band | |
| Issue Price Final | ₹36 per share |
| Lot Size | 3,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 18,48,000 shares (aggregating up to ₹6.65 Cr) |
| Reserved for Market Maker | 96,000 shares Hem Securities Ltd. (aggregating up to ₹0.3456 Cr) |
| Net Offered to Public | 17,52,000 shares (aggregating up to ₹6.31 Cr) |
| Issue Type | Fixed Price IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 43,19,910 shares |
| Share Holding Post Issue | 61,67,910 shares |
Earum IPO offers total 18,48,000 shares. Out of which 8,76,000 (47.40%) allocated to NII, 8,76,000 (47.40%) allocated to RII.
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 96,000 (5.19%) |
| NII (HNI) Shares Offered | 8,76,000 (47.40%) |
| Retail Shares Offered | 8,76,000 (47.40%) |
| Total Shares Offered | 18,48,000 (100.00%) |
Earum Pharmaceuticals IPO opens on June 21, 2019, and closes on June 26, 2019.
| IPO Open Date | Fri, Jun 21, 2019 |
| IPO Close Date | Wed, Jun 26, 2019 |
| Tentative Allotment | Mon, Jul 1, 2019 |
| Initiation of Refunds | Tue, Jul 2, 2019 |
| Credit of Shares to Demat | Wed, Jul 3, 2019 |
| Tentative Listing Date | Thu, Jul 4, 2019 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Jun 26, 2019 |
Investors can bid for a minimum of 3,000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹1,08,000 |
| Retail (Max) | 1 | 3,000 | ₹1,08,000 |
| HNI (Min) | 2 | 6,000 | ₹2,16,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in trading, marketing, distribution of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynaecology drugs, steroids, anti-biotic drugs, cerebral activator drugs, gastrointestinal drugs, etc.
The company is also involved in the trading business of active pharmaceutical ingredients (API's) including Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP and Albendazole IP. Earum Pharmaceuticals is primarily engaged in two types of business activities; marketing of its own formulations products and trading of other brands' generic formulations. Currently, it has around 24 products which are manufactured by 3rd parties and marketed by the company under its brand name.
It has a warehouse at Ahmedabad, Gujarat equipped with all amenities to process business operations smoothly. The company has a domestic and international presence across South East Asia, Latin America and Africa.
Future goals of Earum Pharmaceuticals Ltd are:
1. Make global presence more prominent
2. Enhance customer satisfaction by improving market skills
3. Deal in quality standard products
The competitive strengths of the company are:
1. Wide product range
2. The experienced promoter of 11+ years experience
3. Quality assurance
| Particulars | For the year/period ended (in Rs. Lakhs) | ||||
|---|---|---|---|---|---|
| 31-Dec-18 | 31-Mar-18 | 31-Dec-17 | 31-Mar-16 | ||
| Total Assets | 2,741.00 | 2,052.88 | 1,108.45 | 878.71 | |
| Total Revenue | 3,449.85 | 3,543.67 | 2,333.95 | 1,856.66 | |
| Profit After Tax | 86.51 | 85.65 | 15.98 | 9.76 | |
The Company Earum Pharmaceuticals IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Working Capital requirement | 5.00 |
| 2 | General Corporate Purpose | 0.86 |
| 3 | To meet Issue Expenses | 0.79 |
[Dilip Davda] <p><br />EPL does not own manufacturing unit and is engaged in trading activities only. The issue is fully priced. Third-party contract business raises concern. Currently, the pharma sector is not fancied by investors. Merchant Banker has average track records. Considering all these, investors may skip this issue.</p> Read detail review...
| Listing Date | July 4, 2019 |
| BSE Script Code | 542724 |
| NSE Symbol | |
| ISIN | INE060601015 |
| Final Issue Price | ₹36 per share |
| BSE Listing Group | MT |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹36.00 |
| Open | ₹36.00 |
| Low | ₹36.00 |
| High | ₹36.15 |
| Last Trade | ₹36.05 |
Earum Pharmaceuticals Ltd.
G1, Ground Floor, V R Complex,
Near Sanathal Cross Road, SP Ring Road,
Sanathal,
Ahmedabad, Gujarat, 382210
Phone: +91-79-48402525
Email: cs@earumpharma.com
Website: http://www.earumpharma.com/
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Earum Pharmaceuticals IPO is a SME IPO of 18,48,000 equity shares of the face value of ₹10 aggregating up to ₹6.65 Crores. The issue is priced at ₹36 per share. The minimum order quantity is 3000.
The IPO opens on June 21, 2019, and closes on June 26, 2019.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Earum Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in Earum Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Earum Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Earum Pharmaceuticals IPO opens on June 21, 2019 and closes on June 26, 2019.
Earum Pharmaceuticals IPO lot size is 3000, and the minimum amount required for application is ₹1,08,000.
You can apply in Earum Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Earum Pharmaceuticals IPO will be done on Monday, July 1, 2019, and the allotted shares will be credited to your demat account by Wednesday, July 3, 2019. Check the Earum Pharmaceuticals IPO allotment status.
The Earum Pharmaceuticals IPO listing date is on Thursday, July 4, 2019.
Useful Articles
RHP